Genetic Technologies Ltd (ASX: GTG) Share Price and News
Price
$0.039
Movement
0.00 (0.0)
As at 27 Jun - Closed (20 mins delayed)
52 Week Range
$0.036 - $0.0775
1 Year Return
-48.34%
Genetic Technologies Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Earnings Yield
N/A
Franking
-
Dividend per share
N/A
Year To Date Return
N/A
Shares Outstanding
145.42 million
Earnings per share
-0.008
Share Price
$0.039
Day Change
0.00 (0.0)
52 Week Range
$0.036 - $0.0775
Yesterday's Close
$0.039
Today's Open
–
Days Range
– - –
Volume
0
Avg. Volume (1 month)
0
Turnover
$0
As at 27 Jun - Closed
Genetic Technologies Ltd (ASX: GTG)
Latest News
Investing
Market wipeout: Stocks crushed in $24 billion rush for the exits
Investing
4 stocks soaring on the ASX today
Investing
Genetic Technologies Limited soars 30%: Here's why
About Genetic Technologies Ltd
Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.